Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases

Detalhes bibliográficos
Autor(a) principal: Mion, Olavo de Godoy
Data de Publicação: 2017
Outros Autores: de Mello, Joao Ferreira, Jr., Dutra, Daniel Lorena, de Andrade, Nilvano Alves, de Cerqueira Almeida, Washington Luiz, Anselmo-Lima, Wilma Teresinha, Balsalobre Filho, Leonardo Lopes [UNIFESP], de Carvalho e Castro, Jair [UNIFESP], dos Santos Guimaraesg, Roberto Eustaquio, Lessa, Marcus Miranda, Maniglia, Sergio Fabricio, Meireles, Roberto Campos, Nakanishi, Marcio, Nagata Pignatari, Shirley Shizue [UNIFESP], Roithmann, Renato, Romano, Fabrizio Ricci, Santos, Rodrigo de Paula [UNIFESP], Jorge dos Santos, Marco Cesar [UNIFESP], Tamashiro, Edwin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.bjorl.2017.01.002
https://repositorio.unifesp.br/handle/11600/55041
Resumo: Introduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors' needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugs
id UFSP_5f3b0910f785c7162a1d4465fb537c56
oai_identifier_str oai:repositorio.unifesp.br/:11600/55041
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseasesRhinitisRhinosinusitisAntihistaminesGlucocorticoidsLeukotriene antagonistsIntroduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors' needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugshowever, final considerations about the role of each of them have been made. (C) 2017 Published by Elsevier Editora Ltda. on behalf of Associacao Brasileira de Otorrino-laringologia e Cirurgia Cervico-Facial.Univ Sao Paulo, Disciplina Otorrinolaringol, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med, Dept Otorrinolaringol, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med Ribeirao Preto, Dept Otorrinolaringol, Ribeirao Preto, SP, BrazilUniv Fed Sao Paulo, Ciencias Saude, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, Otorrinolaringol, Sao Paulo, SP, BrazilUniv Fed Minas Gerais, Fac Med, Belo Horizonte, MG, BrazilUniv Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, BrazilUniv Fed Bahia, Fac Med, Disciplina Otorrinolaringol, Salvador, BA, BrazilHosp Inst Paranaense Otorrinolaringol, Centro Rinite & Alergia, Curitiba, PR, BrazilUniv Estado Rio De Janeiro, Rio De Janeiro, RJ, BrazilUniv Brasilia, Fac Med, Brasilia, DF, BrazilUniv Fed Sao Paulo, Dept Otorrinolaringol & Cabeca & Pescoco, Sao Paulo, SP, BrazilUniv Luterana Brasil, Fac Med, Otorrinolaringol, Canoas, RS, BrazilMt Sinai Hosp, Dept Othorhinolaryngol, Toronto, ON, CanadaUniv Sao Paulo, Fac Med, Ciencias, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, BrazilUniv Fed Sao Paulo, Ciencias Saude, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, Otorrinolaringol, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, Dept Otorrinolaringol & Cabeca & Pescoco, Sao Paulo, SP, BrazilWeb of ScienceAssoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial2020-07-17T14:02:48Z2020-07-17T14:02:48Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion215-227application/pdfhttp://dx.doi.org/10.1016/j.bjorl.2017.01.002Brazilian Journal Of Otorhinolaryngology. Sao Paulo, v. 83, n. 2, p. 215-227, 2017.10.1016/j.bjorl.2017.01.002WOS000397985900017.pdf1808-8694https://repositorio.unifesp.br/handle/11600/55041WOS:000397985900017engBrazilian Journal Of OtorhinolaryngologySao Pauloinfo:eu-repo/semantics/openAccessMion, Olavo de Godoyde Mello, Joao Ferreira, Jr.Dutra, Daniel Lorenade Andrade, Nilvano Alvesde Cerqueira Almeida, Washington LuizAnselmo-Lima, Wilma TeresinhaBalsalobre Filho, Leonardo Lopes [UNIFESP]de Carvalho e Castro, Jair [UNIFESP]dos Santos Guimaraesg, Roberto EustaquioLessa, Marcus MirandaManiglia, Sergio FabricioMeireles, Roberto CamposNakanishi, MarcioNagata Pignatari, Shirley Shizue [UNIFESP]Roithmann, RenatoRomano, Fabrizio RicciSantos, Rodrigo de Paula [UNIFESP]Jorge dos Santos, Marco Cesar [UNIFESP]Tamashiro, Edwinreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-03T00:33:54Zoai:repositorio.unifesp.br/:11600/55041Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-03T00:33:54Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
title Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
spellingShingle Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
Mion, Olavo de Godoy
Rhinitis
Rhinosinusitis
Antihistamines
Glucocorticoids
Leukotriene antagonists
title_short Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
title_full Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
title_fullStr Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
title_full_unstemmed Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
title_sort Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases
author Mion, Olavo de Godoy
author_facet Mion, Olavo de Godoy
de Mello, Joao Ferreira, Jr.
Dutra, Daniel Lorena
de Andrade, Nilvano Alves
de Cerqueira Almeida, Washington Luiz
Anselmo-Lima, Wilma Teresinha
Balsalobre Filho, Leonardo Lopes [UNIFESP]
de Carvalho e Castro, Jair [UNIFESP]
dos Santos Guimaraesg, Roberto Eustaquio
Lessa, Marcus Miranda
Maniglia, Sergio Fabricio
Meireles, Roberto Campos
Nakanishi, Marcio
Nagata Pignatari, Shirley Shizue [UNIFESP]
Roithmann, Renato
Romano, Fabrizio Ricci
Santos, Rodrigo de Paula [UNIFESP]
Jorge dos Santos, Marco Cesar [UNIFESP]
Tamashiro, Edwin
author_role author
author2 de Mello, Joao Ferreira, Jr.
Dutra, Daniel Lorena
de Andrade, Nilvano Alves
de Cerqueira Almeida, Washington Luiz
Anselmo-Lima, Wilma Teresinha
Balsalobre Filho, Leonardo Lopes [UNIFESP]
de Carvalho e Castro, Jair [UNIFESP]
dos Santos Guimaraesg, Roberto Eustaquio
Lessa, Marcus Miranda
Maniglia, Sergio Fabricio
Meireles, Roberto Campos
Nakanishi, Marcio
Nagata Pignatari, Shirley Shizue [UNIFESP]
Roithmann, Renato
Romano, Fabrizio Ricci
Santos, Rodrigo de Paula [UNIFESP]
Jorge dos Santos, Marco Cesar [UNIFESP]
Tamashiro, Edwin
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mion, Olavo de Godoy
de Mello, Joao Ferreira, Jr.
Dutra, Daniel Lorena
de Andrade, Nilvano Alves
de Cerqueira Almeida, Washington Luiz
Anselmo-Lima, Wilma Teresinha
Balsalobre Filho, Leonardo Lopes [UNIFESP]
de Carvalho e Castro, Jair [UNIFESP]
dos Santos Guimaraesg, Roberto Eustaquio
Lessa, Marcus Miranda
Maniglia, Sergio Fabricio
Meireles, Roberto Campos
Nakanishi, Marcio
Nagata Pignatari, Shirley Shizue [UNIFESP]
Roithmann, Renato
Romano, Fabrizio Ricci
Santos, Rodrigo de Paula [UNIFESP]
Jorge dos Santos, Marco Cesar [UNIFESP]
Tamashiro, Edwin
dc.subject.por.fl_str_mv Rhinitis
Rhinosinusitis
Antihistamines
Glucocorticoids
Leukotriene antagonists
topic Rhinitis
Rhinosinusitis
Antihistamines
Glucocorticoids
Leukotriene antagonists
description Introduction: Inflammatory conditions of the nose and paranasal sinuses are very prevalent in the general population, resulting in marked loss of quality of life in affected patients, as well as significant work, leisure, and social activity losses. These patients require specific and specialized treatment. A wide range of oral medications are available. Objective: The present document is aimed to clarify, for professionals treating patients with inflammatory sinonasal diseases, both specialists and general practitioners, specific oral therapies in noninfectious nasal inflammatory conditions. Methods: The methodology used to create this article included the search for the key words: oral corticosteroids, antihistamines, antileukotrienes, rhinitis, rhinosinusitis in the MEDLINE and EMBASE databases in the last 5 years. Since no relevant article was found for the text on the subject of interest in the last 5 years, the search was extended for another 5 years, and so on, according to the authors' needs. Results: Relevant literature was found regarding the use of antihistamines, antileukotrienes and oral corticosteroids in these conditions. The Brazilian Academy of Rhinology emphasizes, after extensive discussion by the collegiate, key points in the treatment with these drugs. Conclusion: There is support in the literature for the use of these drugs
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-07-17T14:02:48Z
2020-07-17T14:02:48Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.bjorl.2017.01.002
Brazilian Journal Of Otorhinolaryngology. Sao Paulo, v. 83, n. 2, p. 215-227, 2017.
10.1016/j.bjorl.2017.01.002
WOS000397985900017.pdf
1808-8694
https://repositorio.unifesp.br/handle/11600/55041
WOS:000397985900017
url http://dx.doi.org/10.1016/j.bjorl.2017.01.002
https://repositorio.unifesp.br/handle/11600/55041
identifier_str_mv Brazilian Journal Of Otorhinolaryngology. Sao Paulo, v. 83, n. 2, p. 215-227, 2017.
10.1016/j.bjorl.2017.01.002
WOS000397985900017.pdf
1808-8694
WOS:000397985900017
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brazilian Journal Of Otorhinolaryngology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 215-227
application/pdf
dc.coverage.none.fl_str_mv Sao Paulo
dc.publisher.none.fl_str_mv Assoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial
publisher.none.fl_str_mv Assoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268297760210944